SCHEMBL21035617

SCHEMBL21035617

COC(=O)[C@@H]1CC(=O)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 5/20 0.60
ANPEP P15144 3/20 0.60
CASP3 P42574 1/20 0.43
CYP19A1 P11511 1/20 0.41
MMP3 P08254 6/20 0.41
MMP1 P03956 4/20 0.41
HCRTR1 O43613 4/20 0.41
HCRTR2 O43614 4/20 0.41
MMP9 P14780 2/20 0.41
ADAM17 P78536 1/20 0.41
MMP7 P09237 3/20 0.40
MMP13 P45452 2/20 0.40
MMP8 P22894 4/20 0.39
CYP3A4 P08684 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035533 0.85 CASP3 (0.56) CASP3MMP3MMP1HCRTR1HCRTR2
SCHEMBL21034979 0.82 MMP1 (0.45) MMP2CASP3MMP3MMP1HCRTR1
SCHEMBL21035318 0.82 MMP1 (0.43) MMP2CASP3MMP3MMP1HCRTR1
SCHEMBL21035402 0.82 MMP1 (0.43) MMP2CASP3MMP3MMP1HCRTR1
SCHEMBL21034981 0.82 MMP1 (0.45) MMP2CASP3MMP3MMP1HCRTR1
SCHEMBL21035010 0.81 MMP1 (0.47) CASP3MMP3MMP1HCRTR1HCRTR2
SCHEMBL21035002 0.81 MMP1 (0.47) CASP3MMP3MMP1HCRTR1HCRTR2
SCHEMBL21035522 0.80 MMP1 (0.43) MMP2ANPEPCASP3MMP3MMP1
SCHEMBL6640295 0.79 MMP2 (0.79) MMP2ANPEPMMP3MMP1MMP9
SCHEMBL8498626 0.79 MMP2 (0.79) MMP2ANPEPMMP3MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed